Back

PSA (Prostate specific antigen) screening for prostate cancer

In this paper, it is stated that the determination of PSA (Prostate-Specific Antigen) as a population screening tool for prostate cancer should not be performed. The paper argues that PSA screening does not offer significant benefits in terms of reducing mortality from prostate cancer.

Go To Resource

Key resource information

  • Theme
  • Screening and early detection
  • Topic
  • Clinical practice
  • Format
  • Document
  • Audience
  • Healthcare professionals, Managers
  • Content Type
  • Guidelines

Similar resources

BPMN-based tool for patient pathways

  • Clinical practice
  • External webpage, Video/webinar
  • Healthcare professionals, Researchers
  • Checklist, Learning material
View Resource

How to explain the concept of patient pathways

  • Clinical practice
  • Document
  • Healthcare professionals, Patient advocates, Researchers, Trainers
  • Information resource, Learning material
View Resource

Shared decision-making – From theory to practice

  • Clinical practice, Governance, Research, Team building
  • Video/webinar
  • Healthcare professionals, Managers, Patient advocates, Researchers
  • Learning material
View Resource